Christopher Darr

5PUBLICATIONS
74CO-AUTHORS
Query processing and optimisationPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Obstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 06, 2024
Establishing Medical Intelligence-Leveraging Fast Healthcare Interoperability Resources to Improve Clinical Management: Retrospective Cohort and Clinical Implementation Study.

Alexander Brehmer, Christopher Martin Sauer, Jayson Salazar Rodríguez

|Apr 24, 2024
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz

|Dec 19, 2022
Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance.

Niklas Klümper, Damian J Ralser, Jörg Ellinger

|Oct 12, 2022
Immune-Checkpoint-Inhibitor Therapy-Principles and Relevance of Biomarkers for Pathologists and Oncologists.

Christopher Darr, Thomas Hilser, Claudia Kesch

Pageof 1